Pharmacoeconomic analysis of adjuvant oral capecitabine vs intravenous 5-FU/LV in Dukes' C colon cancer: the X-ACT trial
2006 · British Journal of Cancer · 124 citations
https://doi.org/10.1038/sj.bjc.6603059
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
85
Papers
1.5K
Citations
23
h-index
33
i10-index
C.J. Twelves is an academic researcher from University of Leeds. The author has contributed to research in topics: Cancer Treatment and Pharmacology & Breast Cancer Treatment Studies & Colorectal Cancer Treatments and Studies. The author has an h-index of 23, co-authored 73 publications.
Click to start Chat